255 related articles for article (PubMed ID: 33186555)
1. Drug-Exposome Interactions: The Next Frontier in Precision Medicine.
Pristner M; Warth B
Trends Pharmacol Sci; 2020 Dec; 41(12):994-1005. PubMed ID: 33186555
[TBL] [Abstract][Full Text] [Related]
2. [Application of multiomics mass spectrometry in the research of chemical exposome].
Song YY; Qi ZH; Cai ZW
Se Pu; 2024 Feb; 42(2):120-130. PubMed ID: 38374592
[TBL] [Abstract][Full Text] [Related]
3. The Exposome: Molecules to Populations.
Niedzwiecki MM; Walker DI; Vermeulen R; Chadeau-Hyam M; Jones DP; Miller GW
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():107-127. PubMed ID: 30095351
[TBL] [Abstract][Full Text] [Related]
4. Analyzing Metabolomics Data for Environmental Health and Exposome Research.
Cai Y; Rosen Vollmar AK; Johnson CH
Methods Mol Biol; 2020; 2104():447-467. PubMed ID: 31953830
[TBL] [Abstract][Full Text] [Related]
5. What is new in the exposome?
Vineis P; Robinson O; Chadeau-Hyam M; Dehghan A; Mudway I; Dagnino S
Environ Int; 2020 Oct; 143():105887. PubMed ID: 32619912
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
[TBL] [Abstract][Full Text] [Related]
7. Exploring Single-Cell Exposomics by Mass Spectrometry.
Gao P
Environ Sci Technol; 2023 Aug; 57(33):12201-12209. PubMed ID: 37561608
[TBL] [Abstract][Full Text] [Related]
8. Utilizing a Biology-Driven Approach to Map the Exposome in Health and Disease: An Essential Investment to Drive the Next Generation of Environmental Discovery.
Chung MK; Rappaport SM; Wheelock CE; Nguyen VK; van der Meer TP; Miller GW; Vermeulen R; Patel CJ
Environ Health Perspect; 2021 Aug; 129(8):85001. PubMed ID: 34435882
[TBL] [Abstract][Full Text] [Related]
9. The exposome - a new approach for risk assessment.
Sillé FCM; Karakitsios S; Kleensang A; Koehler K; Maertens A; Miller GW; Prasse C; Quiros-Alcala L; Ramachandran G; Rappaport SM; Rule AM; Sarigiannis D; Smirnova L; Hartung T
ALTEX; 2020; 37(1):3-23. PubMed ID: 31960937
[TBL] [Abstract][Full Text] [Related]
10. Integration of the human exposome with the human genome to advance medicine.
Barouki R; Audouze K; Coumoul X; Demenais F; Gauguier D
Biochimie; 2018 Sep; 152():155-158. PubMed ID: 29960033
[TBL] [Abstract][Full Text] [Related]
11. The exposome and liver disease - how environmental factors affect liver health.
Barouki R; Samson M; Blanc EB; Colombo M; Zucman-Rossi J; Lazaridis KN; Miller GW; Coumoul X
J Hepatol; 2023 Aug; 79(2):492-505. PubMed ID: 36889360
[TBL] [Abstract][Full Text] [Related]
12. Towards a comprehensive characterisation of the human internal chemical exposome: Challenges and perspectives.
David A; Chaker J; Price EJ; Bessonneau V; Chetwynd AJ; Vitale CM; Klánová J; Walker DI; Antignac JP; Barouki R; Miller GW
Environ Int; 2021 Nov; 156():106630. PubMed ID: 34004450
[TBL] [Abstract][Full Text] [Related]
13. EXPOsOMICS: final policy workshop and stakeholder consultation.
Turner MC; Vineis P; Seleiro E; Dijmarescu M; Balshaw D; Bertollini R; Chadeau-Hyam M; Gant T; Gulliver J; Jeong A; Kyrtopoulos S; Martuzzi M; Miller GW; Nawrot T; Nieuwenhuijsen M; Phillips DH; Probst-Hensch N; Samet J; Vermeulen R; Vlaanderen J; Vrijheid M; Wild C; Kogevinas M;
BMC Public Health; 2018 Feb; 18(1):260. PubMed ID: 29448939
[TBL] [Abstract][Full Text] [Related]
14. Reference Standardization for Mass Spectrometry and High-resolution Metabolomics Applications to Exposome Research.
Go YM; Walker DI; Liang Y; Uppal K; Soltow QA; Tran V; Strobel F; Quyyumi AA; Ziegler TR; Pennell KD; Miller GW; Jones DP
Toxicol Sci; 2015 Dec; 148(2):531-43. PubMed ID: 26358001
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics.
Mussap M; Loddo C; Fanni C; Fanos V
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):115-134. PubMed ID: 31958027
[No Abstract] [Full Text] [Related]
16. Characterization of the Human Exposome by a Comprehensive and Quantitative Large-Scale Multianalyte Metabolomics Platform.
González-Domínguez R; Jáuregui O; Queipo-Ortuño MI; Andrés-Lacueva C
Anal Chem; 2020 Oct; 92(20):13767-13775. PubMed ID: 32966057
[TBL] [Abstract][Full Text] [Related]
17. Progress in Characterizing the Human Exposome: a Key Step for Precision Medicine.
Martin-Sanchez F; Bellazzi R; Casella V; Dixon W; Lopez-Campos G; Peek N
Yearb Med Inform; 2020 Aug; 29(1):115-120. PubMed ID: 32303099
[TBL] [Abstract][Full Text] [Related]
18. The metabolome: A key measure for exposome research in epidemiology.
Walker DI; Valvi D; Rothman N; Lan Q; Miller GW; Jones DP
Curr Epidemiol Rep; 2019; 6():93-103. PubMed ID: 31828002
[TBL] [Abstract][Full Text] [Related]
19. Blurred lines: Crossing the boundaries between the chemical exposome and the metabolome.
Balcells C; Xu Y; Gil-Solsona R; Maitre L; Gago-Ferrero P; Keun HC
Curr Opin Chem Biol; 2024 Feb; 78():102407. PubMed ID: 38086287
[TBL] [Abstract][Full Text] [Related]
20. Addressing complexity of health impact assessment in industrially contaminated sites via the exposome paradigm.
Sarigiannis DA; Karakitsios SP
Epidemiol Prev; 2018; 42(5-6S1):37-48. PubMed ID: 30322234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
